Published in Pharma Law Weekly, May 23rd, 2006
Reported net income for the 2006 first quarter was $1,119.6 million compared with $1,078.2 million in the prior year. Reported diluted earnings per share for the 2006 first quarter was $0.82 compared with $0.80 in the prior year.
For the 2006 first quarter, net income was $1,143.8 million. For the 2005 first quarter, net income, assuming stock option expensing, would have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly